logo

$5 And Under

Share SHARE

enteromedics inc. (ETRM) gapped up at the open Friday and has continued to rise in early trade. Shares are now up 1.90 at $8.06 on above average volume. enteromedics is attempting to rebound, following over a 1-week pullback.

Pulmatrix Inc. (PULM) announced Tuesday morning that the FDA has designated PUR1900, its drug candidate for treating fungal infections in the lungs of CF patients, as a "Qualified Infectious Disease Product." Pulmatrix climbed for the bulk of the morning Tuesday and finished with a gain of 0.87 at...

Benitec Biopharma (BNTC) announced Tuesday morning that the European Commission has granted Orphan Drug Designation to BB-301 for the treatment of patients with oculopharyngeal muscular dystrophy. Benitec Biopharma gapped up at the open Tuesday and spiked higher in early trade. The stock settled into...

Pulmatrix Inc. (PULM) announced Tuesday morning that the FDA has designated PUR1900, its drug candidate for treating fungal infections in the lungs of CF patients, as a "Qualified Infectious Disease Product." Pulmatrix has been climbing sharply since the announcement and is now up 0.58 at $1.26....

Benitec Biopharma (BNTC) announced Tuesday morning that the European Commission has granted Orphan Drug Designation to BB-301 for the treatment of patients with oculopharyngeal muscular dystrophy. Benitec Biopharma gapped up at the open Tuesday and has spiked higher in early trade. Shares are now...

Naked Brand Group (NAKD) and Bendon Ltd. announced Friday morning that they have entered into a Letter of Intent for a proposed merger. Naked Brand Group gapped up at the open Friday and has spiked higher in early trade. Shares are now up 1.96 at $3.00 on the highest volume of the year. The stock...

Truett-Hurst Inc. (THST) moved in a narrow range in early trade Thursday, but has broken out sharply in the last 15 minutes on increased volume. The stock is now up 1.18 at $3.16. Truett-Hurst has suddenly surged to a 5 1/2 month high.

Cellect Biotechnology Ltd. (APOP) announced Thursday morning that it has received a formal notice of allowance from the United States Patent & Trademark Office that will protect Cellect's technology and method. Cellect Biotechnology gapped open higher Thursday and has spiked to the upside in early...

Transgenomic Inc. (TBIO) announced Thursday morning that it has entered into a 3-year licensing agreement with LifeLabs. LifeLabs has selected Transgenomic's ICE COLD-PCR technology as its mutation enrichment platform for cancer testing. Transgenomic has gapped open sharply higher Thursday morning...

MYOS RENS Technology (MYOS) moved in a narrow range until mid-morning Wednesday, but climbed steadily for the rest of the session on the highest volume of the year. The stock closed up by 5.52 at $6.82. MYOS RENS Technology soared past resistance and set a new high for the year.

Derma Sciences Inc. (DSCI) announced Wednesday morning that it has agreed to be acquired by Integra LifeSciences (IART) for $7.00 per share of common stock in cash, or approximately $204 million, and $32.00 per share for its outstanding shares of Series A Convertible Preferred Stock and $48.00 per share...

Dextera Surgical Inc. (DXTR) traded in a range at the open Wednesday, but has broken out sharply higher in the last 10 minutes on increased volume. The stock is now up 0.59 at $1.73. Dextera Surgical has surged to a 2-month high and has re-crossed its 50-day moving average.

Derma Sciences Inc. (DSCI) announced Wednesday morning that it has agreed to be acquired by Integra LifeSciences (IART) for $7.00 per share of common stock in cash, or approximately $204 million, and $32.00 per share for its outstanding shares of Series A Convertible Preferred Stock and $48.00 per share...

Biocept Inc. (BIOC) announced Tuesday that it has reached an in-network provider agreement with Blue Cross Blue Shield of Texas. Biocept has gapped open sharply higher Wednesday morning and is now up 1.02 at $2.83 on above average volume. The stock is adding to the sharp gains of the previous session...

Zafgen Inc. (ZFGN) has been climbing sharply since the open of trade Friday. The stock is now up 0.85 at $4.20 on above average volume. Zafgen has broken out of a trading range and has set over a 5-month high.

Follow RTT